Semaxanib

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Other Notes Please note that Sigma-Aldrich provides this product to early discovery researchers as part of a collection of rare and unique chemicals. Sigma-Aldrich does not collect analytical data for this product.

Purity:≥95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:GM CSF was initially characterized as a factor that can support the in vitro colony formation of granulocyte macrophage progenitors. It is also a growth factor for

Purity:≥95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:GM CSF was initially characterized as a factor that can support the in vitro colony formation of granulocyte macrophage progenitors. It is also a growth factor for

Purity:≥95%, by SDS-PAGE visualized with Coomassie® Blue Staining.Description:GM CSF was initially characterized as a factor that can support the in vitro colony formation of granulocyte macrophage progenitors. It is also a growth factor for

Purity≥95% SDS-PAGE.Endotoxin level&lt:0.

Purity≥95% SDS-PAGE.Endotoxin level&lt:0.

Purity≥95% SDS-PAGE.Endotoxin level&lt:0.

Purity≥95% SDS-PAGE.Endotoxin level&lt:0.

Roscovitine (Seliciclib, CYC202) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM. It shows little effect on CDK4/6. Phase 2.A potent and selective inhibitor of cyclin-dependent kinases.

Roscovitine (Seliciclib, CYC202) is a potent and selective CDK inhibitor for Cdc2, CDK2 and CDK5 with IC50 of 0.65 μM, 0.7 μM and 0.16 μM. It shows little effect on CDK4/6. Phase 2.A potent and selective inhibitor of cyclin-dependent kinases.